Cargando…
Durable effect of imatinib and metronomic chemotherapy with capecitabine in pancreatic carcinoma
BACKGROUND: Pancreatic ductal carcinoma (PDC) is a challenging diagnosis with a particularly poor prognosis, even after curative surgery (median survival: <30 months). The prognosis of borderline resectable pancreatic cancer (BR-PDC) is even worse. We describe a patient with BR-PDC who achieved s...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Cancer Intelligence
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10151079/ https://www.ncbi.nlm.nih.gov/pubmed/37138969 http://dx.doi.org/10.3332/ecancer.2023.1535 |